Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan
LAVAL, Quebec, March 14, 2025 - Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC), a global,
diversified pharmaceutical company enriching lives through a relentless drive to deliver better health
outcomes, today provided an update on its financing plans. The Company announced that it has engaged
J.P. Morgan in connection with the Company's previously announced financing objectives.
Any transactions would be subject to market and other conditions and there can
be no assurance that the Company will be able to successfully complete any
transaction on acceptable terms or at all.
This news release does not constitute an offer to sell or the solicitation of
an offer to buy any securities, nor shall there be any sale of securities in
any jurisdiction in which such offer, solicitation or sale, would be unlawful
prior to registration or qualification under the securities laws of any such
jurisdiction.
About Bausch Health
Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC), is a global, diversified
pharmaceutical company enriching lives through our relentless drive to deliver
better health care outcomes. We develop, manufacture and market a range of
products primarily in gastroenterology, hepatology, neurology, dermatology,
dentistry, aesthetics, international pharmaceuticals and eye health, through
our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a
globally integrated healthcare company, trusted and valued by patients, HCPs,
employees and investors. For more information about Bausch Health, visit
www.bauschhealth.com and
connect with us on
LinkedIn.
Forward-looking Statements
This news release may contain forward-looking statements within the meaning of
applicable securities laws, including the safe harbor provisions of the U.S.
Private Securities Litigation Reform Act of 1995. Forward-looking statements
may generally be identified by the use of the words "will," "anticipates,"
"hopes," "expects," "intends," "plans," "should," "could," "would," "may,"
"believes," "subject to" and variations or similar expressions. These
statements are neither historical facts nor assurances of future performance,
are based upon the current expectations and beliefs of management and are
subject to certain risks and uncertainties that could cause actual results to
differ materially from those described in the forward-looking statements.
Actual results are subject to other risks and uncertainties that relate more
broadly to Bausch Health's overall business, including those more fully
described in Bausch Health's most recent annual and quarterly reports and
detailed from time to time in Bausch Health's other filings with the U.S.
Securities and Exchange Commission and the Canadian Securities Administrators,
which factors are incorporated herein by reference. Readers are cautioned not
to place undue reliance on any of these forward-looking statements. These
forward-looking statements speak only as of the date hereof. The Company
undertakes no obligation to update any of these forward-looking statements to
reflect events, information or circumstances after the date of this news
release or to reflect actual outcomes, unless required by law.
